[back] Murder By Injection by Eustace Mullins

Chapter 9. The Drug Trust

In 1987, the eighteen largest drug firms were ranked as follows:

1.  Merck (U.S.) $4.2 billion in sales.
2.  Glaxo Holdings (United Kingdom) $3.4 billion.
3.  Hoffman LaRoche (Switzerland) $3.1 billion.
4.  Smith Kline Beckman (U.S.) $2.8 billion.
5.  Ciba-Geigy (Switzerland) $2.7 billion.
6.  Pfizer (U.S.) $2.5 billion (Standard & Poor's gives its sales as $4 billion).
7.  Hoechst A.G. (Germany) $2.5 billion (Standard & Poor's lists its sales as $38 billion Deutschmarks).
8.  American Home Products (U.S.) $2.4 billion ($4.93 billion according to Standard & Poor's).
9.  Lilly (U.S.) $2.3 billion ($3.72 billion Standard & Poor's).
10.  Upjohn (U.S.) $2 billion.
11.  Squibb (U.S.) $2 billion.
12.  Johnson & Johnson (U.S.) $1.9 billion.
13.  Sandoz (Switzerland) $1.8 billion.
14.  Bristol Myers (U.S.) $1.6 billion.
15.  Beecham Group (United Kingdom) $1.4 billion (Standard & Poor's gives $1.4 billion in sales of the U.S. subsidiary -- $2.6 billion pounds sterling as overall income).
16.  Bayer A.G. (Germany) $1.4 billion (Standard & Poor's gives the figure as $45.9 billion Deutschmarks).
17.  Syntex (U.S.) $1.1 billion.
18.  Warner Lambert (U.S.) $1.1 billion (Standard & Poor's gives the figure as $3.1 billion).

Thus we find that the United States still maintains an overwhelming lead in the production and sale of drugs.  In the United States, the sale of prescription drugs rose in 1987 by 12.5% to $27 billion.  Eleven of the eighteen leading firms are located in the United States; three in Switzerland; two in Germany; and two in the United Kingdom.  Nutritionist T.J. Frye notes that the Drug Trust in the United States is controlled by the Rockefeller group in a cartel relationship with I.G. Farben of Germany.  In fact, I.G. Farben was the largest chemical concern in Germany during the 1930s, when it engaged in an active cartel agreement with Standard Oil of New Jersey.  The Allied Military Government split it up into three companies after World War II, as part of the "anti-cartel" goals of that period, which was not unlike the famed splitting up of Standard Oil itself by court order, while the Rockefellers maintained controlling interest in each of the new companies.  In Germany, General William Draper, of Dillon Read investment bankers, unveiled the new decree from his office in the I.G. Farben building.  Henceforth, I.G. Farben would exist no more; instead, three companies would emerge -- Bayer, of Leverkusen; BASF at Ludwigshafen; and Hoescht, near Frankfort.  Each of the three spawns is now larger than the old I.G. Farben; only ICI of England is larger.  These firms